KOD
HOLD / NEUTRALMeanRevComposite
38.50
Technical
78.70
Fundamental
25.10
Rank
—
Price
89.83
Hurst
0.11
As of
Sep 28, 2026
Daily
Kodiak Sciences Inc
HEALTHCAREBIOTECHNOLOGYKodiak Sciences is a biopharmaceutical firm focused on creating treatments for disorders affecting the retina, with operations across the U.S. and global markets. Based in Palo Alto, California, the company is currently in clinical development stages of its therapeutic candidates.
Market cap
$5.7B
P/E (trailing)
—
P/E (forward)
—
PEG ratio
—
Dividend yield
—
Beta
2.18
52w range
10.94 – 95.77
Return on equity
-368.40%
Profit margin
0.00%
Revenue growth
0.00%
Earnings growth
0.00%
Price history
1Y: 89.92 (+473.5%) · range 11.60–89.92
Cycle position
96/ 100 cycle scoreEXIT ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 8 · NOT READY · exit proximity 78
Conviction
32/ 100 · maturity 14%
VScore.0924
Buildup.3070
EMA entry setup.388
Fundamentals.2325
Volume profile
POC
36.52
Price vs POC
+147.0%
Overhead supply
4%
Runway
open sky
Value area 29.21–46.49 · 4% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trader-sentiment | 1.000 | Sep 28, 2026 |
| forum-chatter | 0.586 | Sep 28, 2026 |
Pattern & cluster
Pattern
NEUTRAL
Cluster
NEUTRALForward returns
Not yet labeled — the study prices these as positions mature.